Full Text View
Tabular View
No Study Results Posted
Related Studies
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
This study has been terminated.
( Persantine is no longer being used at UCHC for pharmacological stress testing )
Study NCT00760708   Information provided by University of Connecticut Health Center

First Received on September 24, 2008.   Last Updated on January 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemia
Coronary Disease
Additional conditions recognized in this trial
Coronary Artery Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Myocardial Ischemia
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Adenosine
Dipyridamole
More general drug interventions related to this trial
Analgesics
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Connecticut Health Center
Department of Defense


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services